Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends



Rating:

Share or cite this content

Citations should be made in the following way:
A. Denis (Liège, Belgium), M. Henket (Liège, Belgium), F. Gester (Liège, Belgium), M. Thys (Liège, Belgium), M. Ernst (Liège, Belgium), N. Maes (Liège, Belgium), L. Giltay (Liège, Belgium), A. Frix (Liège, Belgium), Q. Maloir (Liège, Belgium), C. Desir (Liège, Belgium), P. Meunier (Liège, Belgium), R. Louis (Liège, Belgium), J. Guiot (Liège, Belgium). Incidence, prevalence and mortality of rheumatoid arthritis-associated interstitial lung disease : a retrospective study. 2542

Member's Comments

No comment yet.

Related content which might interest you: Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease Source: Eur Respir J 2016; 47: 588-596 Year: 2016 Mortality and clinical features in rheumatoid arthritis and interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Prognosis in rheumatoid arthritis patients with COPD: A nationwide, registry-based study Source: International Congress 2017 – COPD: risk factors and prognosis Year: 2017 Interstitial lung disease in new onset rheumatoid arthritis: a 5 year prospective study Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Duration of rheumatoid arthritis and the risk of developing interstitial lung disease Source: ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020 Year: 2021 Risk factors of interstitial lung diseases in patients with rheumatoid arthritis. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Increasing mortality rate due to rheumatoid arthritis-related lung diseases in Japan Source: ERJ Open Res, 6 (1) 00217-2019; 10.1183/23120541.00217-2019 Year: 2020 Prevalence of pulmonary involvement in rheumatoid arthritis patients in Indian population Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Impact of chronic obstructive pulmonary disease on specific-cause of mortality: a national cohort study Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Rheumatoid arthritis-associated interstitial lung disease: time trends Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021 Characteristics and predictors of outcome in rheumatoid arthritis related ILD Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Predicting outcomes in rheumatoid arthritis related interstitial lung disease Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018 Year: 2019 Risk factors for postoperative acute exacerbation of interstitial lung diseases: a matched case-control study Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 Interstitial lung disease in patients with rheumatoid arthritis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Interstitial lung disease in a single center inception cohort of early rheumatoid arthritis patients Source: International Congress 2015 – Connective tissue disorders Year: 2015 Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new Source: Breathe, 16 (4) 200223; 10.1183/20734735.0223-2020 Year: 2020